- Momentum Global Ventures completes €200 million Series B investment in Perpetual Next by 2026.
- €70 million additional capital committed for 2025 and 2026.
- Funds support biomethanol production expansion in Europe and the US.
- Perpetual Next collaborates with Air Liquide, Fluor, and ING Corporate Finance.
Investment Overview
Momentum Global Ventures has announced the completion of its €200 million Series B investment in Perpetual Next by 2026. This investment aims to enhance Perpetual Next's capabilities in developing biocommodity production sites, focusing primarily on biomethanol.
Capital Allocation
By the start of 2025, Momentum's affiliates had invested €137 million in Series B capital. An additional €30 million was added by the end of 2025, with a further €40 million committed for 2026. This brings the total Series B capital to approximately €200 million.
Facility Expansion
The capital is allocated for constructing and expanding production facilities in countries like the Netherlands and Estonia. A significant project includes developing the world's largest torrefaction reactor, in collaboration with technology partner TSI.
Biomethanol Blueprint
Perpetual Next is rolling out a biomethanol production blueprint at four sites in Europe and the US. Developed with Air Liquide and Fluor, this blueprint aims for rapid scale-up, targeting 220,000 tons of biomethanol annually per site.
Financial Strategy
Momentum's investment is fully contributed as share capital, making Perpetual Next the sole shareholder of its methanol production sites. This strategy leaves room for growth financing, with ING Corporate Finance supporting the raising of additional capital and onboarding strategic partners.
